By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Zogenix, Inc. 

12760 High Bluff Drive
Suite 130
San Diego  California  92130  U.S.A.
Phone: 858-259-1165 Fax: 858-259-1166


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Zogenix (ZGNX) Provides Corporate Update And Reports Fourth Quarter And Full-Year 2016 Financial Results 3/10/2017 11:04:19 AM
Zogenix (ZGNX) To Release Fourth Quarter And Full-Year 2016 Financial Results And Host Conference Call And Webcast On March 9 3/2/2017 8:20:32 AM
Zogenix (ZGNX) Receives Orphan Drug Designation In The European Union For ZX008 In Lennox Gastaut Syndrome 3/1/2017 11:17:32 AM
Zogenix (ZGNX) Announces Initiation Of Clinical Efficacy Portion Of Study 1504 For ZX008 In Dravet Syndrome 2/13/2017 8:17:40 AM
Zogenix (ZGNX) Announces Issuance Of U.S. Patent for ZX008 In Dravet Syndrome 1/30/2017 7:43:32 AM
Zogenix (ZGNX) Announces CFO Transition 1/6/2017 8:51:00 AM
Zogenix (ZGNX) Announces New Efficacy And Safety Data For ZX008 In Treatment Of Seizures In Lennox Gastaut Syndrome & Dravet Syndrome 12/5/2016 8:24:05 AM
New Data On Zogenix (ZGNX)’s ZX008 For Lennox Gastaut Syndrome & Dravet Syndrome To Be Presented At 70th Annual American Epilepsy Society Meeting 11/23/2016 7:44:27 AM
Zogenix (ZGNX) To Release Third Quarter 2016 Financial Results And Host Conference Call And Webcast On November 7 10/31/2016 8:04:37 AM
Zogenix (ZGNX) To Participate In Two Upcoming Investor Conferences 9/20/2016 8:16:55 AM
12345678910...
//-->